Drug Shortage Report for DALACIN C PHOSPHATE

Last updated on 2021-10-14 History
Report ID 146307
Drug Identification Number 00260436
Brand name DALACIN C PHOSPHATE
Common or Proper name DALACIN C PHOSPHATE
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) CLINDAMYCIN
Strength(s) 150MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 1 x 60mL
ATC code J01FF
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2021-10-01
Estimated end date
Actual end date 2021-10-13
Shortage status Resolved
Updated date 2021-10-14
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-10-14 English Compare
v7 2021-10-13 French Compare
v6 2021-10-13 English Compare
v5 2021-10-02 English Compare
v4 2021-10-01 French Compare
v3 2021-10-01 English Compare
v2 2021-09-28 French Compare
v1 2021-09-28 English Compare